Assignee
BOSTON BIOMEDICAL INC
US·13 granted patents·30 pending applications·24 citations·filing 2014–2019
Top patents by PatentIndex Score
43 records- 0187US10377731B2Compositions and methods for cancer treatmentBOSTON BIOMEDICAL INC·Filed 2019·Granted Aug 13, 2019·3 cites·3 claims
- 0285US9381184B2Compounds and compositions for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2015·Granted Jul 5, 2016·4 cites·37 claims
- 0384US9834532B2Stat3 pathway inhibitors and cancer stem cell inhibitorsBOSTON BIOMEDICAL INC·Filed 2014·Granted Dec 5, 2017·4 cites·6 claims
- 0483US9795595B2Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2015·Granted Oct 24, 2017·3 cites·28 claims
- 0580US9187454B2Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereofBOSTON BIOMEDICAL INC·Filed 2014·Granted Nov 17, 2015·4 cites·18 claims
- 0678US10017488B23-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereofBOSTON BIOMEDICAL INC·Filed 2015·Granted Jul 10, 2018·2 cites·17 claims
- 0776US10683274B23-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereofBOSTON BIOMEDICAL INC·Filed 2018·Granted Jun 16, 2020·1 cites·1 claims
- 0874US10934309B2Tricyclic quinone derivativeBOSTON BIOMEDICAL INC·Filed 2018·Granted Mar 2, 2021·1 cites·1 claims
- 0973US10543189B22-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancerBOSTON BIOMEDICAL INC·Filed 2019·Granted Jan 28, 2020·1 cites·15 claims
- 1071US10646464B2Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2018·Granted May 12, 2020·1 cites·6 claims
- 1171US2020039948A1Novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitorsBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1268US2019085327A1Bacteria-Mediated Gene Modulation Via microRNA MachineryBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1367US2018030022A1Novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitorsBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 1466US2018030021A1Novel compositions and methods for cancer treatmentBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 1564US2017197932A1Novel stat3 pathway inhibitors and cancer stem cell inhibitorsBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 1663US2019224157A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2019·Application pending·0 cites
- 1762US9725444B2Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinasesBOSTON BIOMEDICAL INC·Filed 2014·Granted Aug 8, 2017·0 cites·18 claims
- 1862US2019248781A1Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinasesBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1960US2019231735A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2019·Application pending·0 cites
- 2059US2019241550A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 2159US2018022743A1Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinasesBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 2258US2018193303A1Novel compounds and compositions for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 2357US2019262319A1Novel methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 2455US10800752B2Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancerBOSTON BIOMEDICAL INC·Filed 2018·Granted Oct 13, 2020·0 cites·12 claims
- 2555US10183925B2Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Granted Jan 22, 2019·0 cites·14 claims
- 2654US2016030384A12-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancerBOSTON BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 2754US2018193318A1Novel methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 2854US2016271099A1Novel compounds and compositions for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 2951US2018250260A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 3051US2016075697A1Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivativeBOSTON BIOMEDICAL INC·Filed 2015·Application pending·0 cites
- 3149US2020237711A1Compositions for Treating and/or Preventing CancerBOSTON BIOMEDICAL INC·Filed 2019·Application pending·0 cites
- 3248US2016031888A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 3347US2019241569A13-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancerBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 3447US2019076392A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 3547US2017319537A1Novel methods for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 3645US2019249134A1Cell cultures and use thereofBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 3743US2018250261A1Method for treating cancer with a stat3 pathway inhibitor and kinase inhibitorBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 3839US2019375723A1New Naphtho[2,3-B]Furan DerivativesBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 3938US2018140572A1Compositions comprising a cancer stemness inhibitor and an immunotherapeutic agent for use in treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 4037US2017015677A1New tricyclic quinone derivativeBOSTON BIOMEDICAL INC·Filed 2015·Application pending·0 cites
- 4135US2017016001A1Asymmetric interfering rna compositions that silence k-ras and methods of uses thereofBOSTON BIOMEDICAL INC·Filed 2015·Application pending·0 cites
- 4235US2018085341A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 4334US2018098959A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BOSTON BIOMEDICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →